The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury

Clinical trial NCT01597635 · COMPLETED

Trial details

NCT number: NCT01597635
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Injury, Acute

Start date: 2012-09-01
Primary completion: 2014-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.